跳至主要内容
临床试验/JPRN-UMIN000001006
JPRN-UMIN000001006已完成4 期

The additive effects of Pranlukast in stable asthmatic patients with the regular use of FP/LABA combination drug –(1) Open-label, randomized and comparative study– - The additive effects of Pranlukast in stable asthmatic patients with the regular use of FP/LABA combination drug –(1) Open-label, randomized and comparative study–

JA Tohno Kousei Hospital0 个研究点目标入组 50 人开始时间: 2008年2月4日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Past treatments with anti-LT drugs in the previous 3 months. 2.Past treatments with oral corticosteroids in the previous 2 weeks. 3.Chronic obstructive lung disease (COPD) and other respitatory disease. 4.Severe liver, kidney, heart , hematic and other diseases 5.Inappropriate patients from the doctor's viewpoint.

研究者

发起方
JA Tohno Kousei Hospital

相似试验